

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.62115140 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.62115140 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.30367484 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.30367484 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.91508696 |
| 6 | indole-containing compound catabolic process (GO:0042436) | 6.29863365 |
| 7 | indolalkylamine catabolic process (GO:0046218) | 6.29863365 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.29863365 |
| 9 | glyoxylate metabolic process (GO:0046487) | 6.08311932 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.03741716 |
| 11 | tryptophan metabolic process (GO:0006568) | 5.92519003 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.92102068 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.90395638 |
| 14 | cysteine metabolic process (GO:0006534) | 5.64891513 |
| 15 | urea metabolic process (GO:0019627) | 5.54632392 |
| 16 | urea cycle (GO:0000050) | 5.54632392 |
| 17 | alpha-linolenic acid metabolic process (GO:0036109) | 5.46564683 |
| 18 | sulfur amino acid catabolic process (GO:0000098) | 5.35600258 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.34257993 |
| 20 | serine family amino acid catabolic process (GO:0009071) | 5.28069409 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.22714193 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.18194393 |
| 23 | protein carboxylation (GO:0018214) | 5.18194393 |
| 24 | complement activation, alternative pathway (GO:0006957) | 5.17272739 |
| 25 | regulation of plasminogen activation (GO:0010755) | 5.16437263 |
| 26 | regulation of protein activation cascade (GO:2000257) | 5.14799993 |
| 27 | regulation of fibrinolysis (GO:0051917) | 5.14586736 |
| 28 | nitrogen cycle metabolic process (GO:0071941) | 5.11186462 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.05460541 |
| 30 | lysine metabolic process (GO:0006553) | 5.03892401 |
| 31 | lysine catabolic process (GO:0006554) | 5.03892401 |
| 32 | bile acid metabolic process (GO:0008206) | 5.03142743 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 5.02716868 |
| 34 | homocysteine metabolic process (GO:0050667) | 4.94793917 |
| 35 | regulation of complement activation (GO:0030449) | 4.81570035 |
| 36 | tyrosine metabolic process (GO:0006570) | 4.75679617 |
| 37 | alpha-amino acid catabolic process (GO:1901606) | 4.72017535 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 4.71812895 |
| 39 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.57072647 |
| 40 | reverse cholesterol transport (GO:0043691) | 4.56246702 |
| 41 | cellular ketone body metabolic process (GO:0046950) | 4.54923990 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 4.54883796 |
| 43 | regulation of cholesterol esterification (GO:0010872) | 4.51984913 |
| 44 | proline metabolic process (GO:0006560) | 4.51979884 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.47614224 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.47614224 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.47614224 |
| 48 | indolalkylamine metabolic process (GO:0006586) | 4.46393831 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.44597137 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.44597137 |
| 51 | glycine metabolic process (GO:0006544) | 4.41198996 |
| 52 | cellular glucuronidation (GO:0052695) | 4.40828115 |
| 53 | coenzyme catabolic process (GO:0009109) | 4.38019735 |
| 54 | serine family amino acid metabolic process (GO:0009069) | 4.37778013 |
| 55 | cellular amino acid catabolic process (GO:0009063) | 4.36997648 |
| 56 | intestinal cholesterol absorption (GO:0030299) | 4.36468395 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 4.36413039 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.36413039 |
| 59 | amine catabolic process (GO:0009310) | 4.35689867 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 4.35689867 |
| 61 | glutamate metabolic process (GO:0006536) | 4.34817850 |
| 62 | bile acid and bile salt transport (GO:0015721) | 4.32409066 |
| 63 | protein-lipid complex assembly (GO:0065005) | 4.30446623 |
| 64 | epoxygenase P450 pathway (GO:0019373) | 4.29627515 |
| 65 | phospholipid efflux (GO:0033700) | 4.24897472 |
| 66 | cellular modified amino acid catabolic process (GO:0042219) | 4.24873600 |
| 67 | drug catabolic process (GO:0042737) | 4.22739380 |
| 68 | benzene-containing compound metabolic process (GO:0042537) | 4.22620564 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 4.22434298 |
| 70 | plasma lipoprotein particle clearance (GO:0034381) | 4.14468291 |
| 71 | serine family amino acid biosynthetic process (GO:0009070) | 4.13666203 |
| 72 | ethanol oxidation (GO:0006069) | 4.12734154 |
| 73 | plasma lipoprotein particle organization (GO:0071827) | 4.12373505 |
| 74 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.07491857 |
| 75 | urate metabolic process (GO:0046415) | 4.07395497 |
| 76 | drug transmembrane transport (GO:0006855) | 4.06428813 |
| 77 | aldehyde catabolic process (GO:0046185) | 4.03100343 |
| 78 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.02000245 |
| 79 | regulation of apoptotic cell clearance (GO:2000425) | 3.97985131 |
| 80 | uronic acid metabolic process (GO:0006063) | 3.97205449 |
| 81 | glucuronate metabolic process (GO:0019585) | 3.97205449 |
| 82 | cholesterol efflux (GO:0033344) | 3.96074781 |
| 83 | protein-lipid complex subunit organization (GO:0071825) | 3.94787433 |
| 84 | ketone body metabolic process (GO:1902224) | 3.94055789 |
| 85 | arginine metabolic process (GO:0006525) | 3.92882874 |
| 86 | short-chain fatty acid metabolic process (GO:0046459) | 3.90586474 |
| 87 | fibrinolysis (GO:0042730) | 3.85426064 |
| 88 | regulation of cholesterol metabolic process (GO:0090181) | 3.83088276 |
| 89 | acetyl-CoA metabolic process (GO:0006084) | 3.82771031 |
| 90 | carboxylic acid catabolic process (GO:0046395) | 3.82449394 |
| 91 | organic acid catabolic process (GO:0016054) | 3.82449394 |
| 92 | omega-hydroxylase P450 pathway (GO:0097267) | 3.81349424 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 3.79943599 |
| 94 | plasma lipoprotein particle assembly (GO:0034377) | 3.78497402 |
| 95 | exogenous drug catabolic process (GO:0042738) | 3.78392026 |
| 96 | regulation of bile acid biosynthetic process (GO:0070857) | 3.76025118 |
| 97 | cofactor catabolic process (GO:0051187) | 3.75241104 |
| 98 | low-density lipoprotein particle remodeling (GO:0034374) | 3.74642290 |
| 99 | regulation of cholesterol homeostasis (GO:2000188) | 3.73550067 |
| 100 | acute-phase response (GO:0006953) | 3.72168255 |
| 101 | phospholipid homeostasis (GO:0055091) | 3.71823461 |
| 102 | aspartate family amino acid catabolic process (GO:0009068) | 3.69596089 |
| 103 | blood coagulation, intrinsic pathway (GO:0007597) | 3.66564407 |
| 104 | cholesterol homeostasis (GO:0042632) | 3.64838706 |
| 105 | complement activation, classical pathway (GO:0006958) | 3.61923159 |
| 106 | sterol homeostasis (GO:0055092) | 3.60207453 |
| 107 | flavonoid metabolic process (GO:0009812) | 3.59785706 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.58848658 |
| 109 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.58848658 |
| 110 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.58189017 |
| 111 | complement activation (GO:0006956) | 3.57654355 |
| 112 | response to nitrosative stress (GO:0051409) | 3.56914022 |
| 113 | cytolysis (GO:0019835) | 3.56234483 |
| 114 | 2-oxoglutarate metabolic process (GO:0006103) | 3.55622137 |
| 115 | proline biosynthetic process (GO:0006561) | 3.53528120 |
| 116 | mannose metabolic process (GO:0006013) | 3.51593188 |
| 117 | negative regulation of lipid transport (GO:0032369) | 3.51445044 |
| 118 | negative regulation of hemostasis (GO:1900047) | 3.41805132 |
| 119 | negative regulation of blood coagulation (GO:0030195) | 3.41805132 |
| 120 | positive regulation of hemostasis (GO:1900048) | 3.32181070 |
| 121 | positive regulation of blood coagulation (GO:0030194) | 3.32181070 |
| 122 | negative regulation of fatty acid transport (GO:2000192) | 3.29764219 |
| 123 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.26403374 |
| 124 | negative regulation of lipase activity (GO:0060192) | 3.24460495 |
| 125 | lipoprotein metabolic process (GO:0042157) | 3.19732458 |
| 126 | positive regulation of steroid metabolic process (GO:0045940) | 3.13264411 |
| 127 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.08812068 |
| 128 | protein activation cascade (GO:0072376) | 3.08454132 |
| 129 | positive regulation of extracellular matrix organization (GO:1903055) | 3.08310173 |
| 130 | positive regulation of coagulation (GO:0050820) | 3.03519787 |
| 131 | negative regulation of coagulation (GO:0050819) | 3.02869642 |
| 132 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.01754262 |
| 133 | regulation of lipoprotein particle clearance (GO:0010984) | 2.96649152 |
| 134 | negative regulation of wound healing (GO:0061045) | 2.94276950 |
| 135 | opsonization (GO:0008228) | 2.94007428 |
| 136 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.92057295 |
| 137 | regulation of humoral immune response (GO:0002920) | 2.90647085 |
| 138 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.90457280 |
| 139 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.89288416 |
| 140 | negative regulation of cell size (GO:0045792) | 2.87470511 |
| 141 | regulation of extracellular matrix organization (GO:1903053) | 2.86054417 |
| 142 | regulation of extracellular matrix disassembly (GO:0010715) | 2.84727722 |
| 143 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.82879854 |
| 144 | cholesterol transport (GO:0030301) | 2.82707068 |
| 145 | sterol transport (GO:0015918) | 2.82707068 |
| 146 | drug metabolic process (GO:0017144) | 2.79610167 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.39115218 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.18734155 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.84534987 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48860452 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.22354084 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.96620443 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.80300282 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.04860081 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.95956221 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.12750926 |
| 11 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.65148115 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.47579796 |
| 13 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.32484172 |
| 14 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.30358919 |
| 15 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.26567517 |
| 16 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.22036251 |
| 17 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.20327554 |
| 18 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.16003178 |
| 19 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.12027611 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.11339736 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.09951015 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03583474 |
| 23 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.01709620 |
| 24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8722624 |
| 25 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.84994175 |
| 26 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.81510241 |
| 27 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.64524164 |
| 28 | P68_20966046_ChIP-Seq_HELA_Human | 1.62506949 |
| 29 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.60201531 |
| 30 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.58383352 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56582445 |
| 32 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.51024183 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48225412 |
| 34 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.48157557 |
| 35 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.45953193 |
| 36 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.44139903 |
| 37 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43732778 |
| 38 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.43113756 |
| 39 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42419885 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.40312842 |
| 41 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.39275295 |
| 42 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.39146750 |
| 43 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.37728033 |
| 44 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.37074400 |
| 45 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33736471 |
| 46 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.32753359 |
| 47 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32618315 |
| 48 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.31884497 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.31762909 |
| 50 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31588656 |
| 51 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.29035869 |
| 52 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.27315401 |
| 53 | MAF_26560356_Chip-Seq_TH1_Human | 1.23981289 |
| 54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.23360254 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.21263467 |
| 56 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20791035 |
| 57 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19791243 |
| 58 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18307287 |
| 59 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18084209 |
| 60 | MAF_26560356_Chip-Seq_TH2_Human | 1.17934030 |
| 61 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15362526 |
| 62 | ATF3_27146783_Chip-Seq_COLON_Human | 1.15116414 |
| 63 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.14901086 |
| 64 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13691041 |
| 65 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.13478482 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.12214866 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11890877 |
| 68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10517149 |
| 69 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.10415683 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09415542 |
| 71 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09307182 |
| 72 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08666689 |
| 73 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08431642 |
| 74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07783992 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07157644 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05888978 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04389823 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03399620 |
| 79 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02879407 |
| 80 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02720796 |
| 81 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02697153 |
| 82 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02690621 |
| 83 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02528116 |
| 84 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.01351593 |
| 85 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.00743138 |
| 86 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.00118315 |
| 87 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.99806746 |
| 88 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.98698195 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.95046984 |
| 90 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91351941 |
| 91 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.90994829 |
| 92 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.89672114 |
| 93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.88505749 |
| 94 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.87536006 |
| 95 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85883750 |
| 96 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.82158466 |
| 97 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80472409 |
| 98 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80378600 |
| 99 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.75809912 |
| 100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.75728524 |
| 101 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.75229978 |
| 102 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73977010 |
| 103 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72885276 |
| 104 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72346240 |
| 105 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71761311 |
| 106 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71646092 |
| 107 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71492166 |
| 108 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.68275458 |
| 109 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.67007834 |
| 110 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.66295910 |
| 111 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.64247473 |
| 112 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.64247473 |
| 113 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.63798638 |
| 114 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63095803 |
| 115 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.62712203 |
| 116 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62465773 |
| 117 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.60853265 |
| 118 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.59060629 |
| 119 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.58358007 |
| 120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.57323470 |
| 121 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56738379 |
| 122 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55696465 |
| 123 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55243079 |
| 124 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.55112779 |
| 125 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.54005904 |
| 126 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53618182 |
| 127 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53419780 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.52241068 |
| 129 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.51083144 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.50648242 |
| 131 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50051656 |
| 132 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.49863869 |
| 133 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49119842 |
| 134 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.48419522 |
| 135 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48379207 |
| 136 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.47262217 |
| 137 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45898807 |
| 138 | GATA2_19941826_ChIP-Seq_K562_Human | 0.45863425 |
| 139 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45633714 |
| 140 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.45081018 |
| 141 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.43989955 |
| 142 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.43113912 |
| 143 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.42911818 |
| 144 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.42200717 |
| 145 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40517685 |
| 146 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.39929051 |
| 147 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.39205072 |
| 148 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.37998456 |
| 149 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.37281306 |
| 150 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.37119264 |
| 151 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.37107287 |
| 152 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.37000128 |
| 153 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36589453 |
| 154 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.36310684 |
| 155 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.35618801 |
| 156 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35287209 |
| 157 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.34913965 |
| 158 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34904301 |
| 159 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.34608084 |
| 160 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.34565064 |
| 161 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.34451433 |
| 162 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.34193250 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.41944520 |
| 2 | * MP0005360_urolithiasis | 7.12010620 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.37450078 |
| 4 | MP0005365_abnormal_bile_salt | 6.12994363 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.17019317 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.19403481 |
| 7 | MP0003252_abnormal_bile_duct | 4.00222872 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.47146063 |
| 9 | MP0003172_abnormal_lysosome_physiology | 3.10880072 |
| 10 | MP0009840_abnormal_foam_cell | 3.10654466 |
| 11 | MP0003195_calcinosis | 3.04279200 |
| 12 | MP0005332_abnormal_amino_acid | 3.03385537 |
| 13 | MP0005083_abnormal_biliary_tract | 3.02705092 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.56234404 |
| 15 | MP0005076_abnormal_cell_differentiation | 2.55755686 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.48102828 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.29575590 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.29351283 |
| 19 | * MP0000609_abnormal_liver_physiology | 2.11598513 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 2.08716480 |
| 21 | MP0003868_abnormal_feces_composition | 1.85982404 |
| 22 | * MP0005319_abnormal_enzyme/_coenzyme | 1.80920002 |
| 23 | MP0001764_abnormal_homeostasis | 1.67913276 |
| 24 | MP0000566_synostosis | 1.66710454 |
| 25 | MP0001849_ear_inflammation | 1.66367299 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.63756481 |
| 27 | MP0002249_abnormal_larynx_morphology | 1.62758296 |
| 28 | MP0008260_abnormal_autophagy | 1.62321655 |
| 29 | MP0004185_abnormal_adipocyte_glucose | 1.61646440 |
| 30 | MP0002089_abnormal_postnatal_growth/wei | 1.54004489 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.52943769 |
| 32 | * MP0009643_abnormal_urine_homeostasis | 1.47695142 |
| 33 | MP0005409_darkened_coat_color | 1.45945327 |
| 34 | MP0009697_abnormal_copulation | 1.43275769 |
| 35 | MP0005451_abnormal_body_composition | 1.40625165 |
| 36 | MP0003186_abnormal_redox_activity | 1.37863866 |
| 37 | MP0004858_abnormal_nervous_system | 1.36796115 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.36443906 |
| 39 | MP0003011_delayed_dark_adaptation | 1.26926201 |
| 40 | MP0001915_intracranial_hemorrhage | 1.24724878 |
| 41 | MP0000858_altered_metastatic_potential | 1.19628746 |
| 42 | * MP0000598_abnormal_liver_morphology | 1.16202123 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.11978418 |
| 44 | * MP0005636_abnormal_mineral_homeostasis | 1.11220270 |
| 45 | MP0005647_abnormal_sex_gland | 1.10901608 |
| 46 | MP0004947_skin_inflammation | 1.09302975 |
| 47 | MP0003453_abnormal_keratinocyte_physiol | 1.08410583 |
| 48 | MP0003705_abnormal_hypodermis_morpholog | 1.07744243 |
| 49 | MP0009764_decreased_sensitivity_to | 1.06025795 |
| 50 | MP0000678_abnormal_parathyroid_gland | 1.03976835 |
| 51 | MP0010234_abnormal_vibrissa_follicle | 1.03857782 |
| 52 | MP0000604_amyloidosis | 1.02675124 |
| 53 | MP0005375_adipose_tissue_phenotype | 1.02001307 |
| 54 | MP0003091_abnormal_cell_migration | 1.00135877 |
| 55 | MP0009763_increased_sensitivity_to | 0.98788680 |
| 56 | MP0008438_abnormal_cutaneous_collagen | 0.96614990 |
| 57 | MP0003879_abnormal_hair_cell | 0.95562981 |
| 58 | MP0004233_abnormal_muscle_weight | 0.95387154 |
| 59 | MP0000003_abnormal_adipose_tissue | 0.94322378 |
| 60 | MP0002254_reproductive_system_inflammat | 0.91525409 |
| 61 | MP0006036_abnormal_mitochondrial_physio | 0.90067816 |
| 62 | MP0001348_abnormal_lacrimal_gland | 0.89651223 |
| 63 | MP0005084_abnormal_gallbladder_morpholo | 0.89626490 |
| 64 | MP0005670_abnormal_white_adipose | 0.89440056 |
| 65 | * MP0009642_abnormal_blood_homeostasis | 0.88966091 |
| 66 | * MP0008469_abnormal_protein_level | 0.87600824 |
| 67 | MP0005408_hypopigmentation | 0.87483413 |
| 68 | MP0001873_stomach_inflammation | 0.85062605 |
| 69 | MP0005023_abnormal_wound_healing | 0.84106371 |
| 70 | MP0010368_abnormal_lymphatic_system | 0.83006328 |
| 71 | MP0000767_abnormal_smooth_muscle | 0.82596200 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.82081357 |
| 73 | MP0001756_abnormal_urination | 0.81041770 |
| 74 | MP0005220_abnormal_exocrine_pancreas | 0.80806712 |
| 75 | MP0002078_abnormal_glucose_homeostasis | 0.79850837 |
| 76 | MP0009765_abnormal_xenobiotic_induced | 0.77997877 |
| 77 | MP0005376_homeostasis/metabolism_phenot | 0.77658385 |
| 78 | MP0003115_abnormal_respiratory_system | 0.75531474 |
| 79 | MP0004883_abnormal_blood_vessel | 0.75413452 |
| 80 | MP0001661_extended_life_span | 0.74441405 |
| 81 | MP0005535_abnormal_body_temperature | 0.72464771 |
| 82 | MP0002971_abnormal_brown_adipose | 0.70731188 |
| 83 | MP0003279_aneurysm | 0.70502223 |
| 84 | MP0002132_abnormal_respiratory_system | 0.70416009 |
| 85 | MP0004043_abnormal_pH_regulation | 0.69272374 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.68144757 |
| 87 | MP0005334_abnormal_fat_pad | 0.67172265 |
| 88 | MP0004130_abnormal_muscle_cell | 0.64095051 |
| 89 | * MP0002136_abnormal_kidney_physiology | 0.63571301 |
| 90 | MP0000467_abnormal_esophagus_morphology | 0.63478471 |
| 91 | MP0003690_abnormal_glial_cell | 0.63118349 |
| 92 | MP0002928_abnormal_bile_duct | 0.62938770 |
| 93 | MP0000371_diluted_coat_color | 0.62678695 |
| 94 | MP0005266_abnormal_metabolism | 0.62219473 |
| 95 | MP0003329_amyloid_beta_deposits | 0.62022164 |
| 96 | MP0009278_abnormal_bone_marrow | 0.61861746 |
| 97 | MP0005257_abnormal_intraocular_pressure | 0.60912552 |
| 98 | MP0002933_joint_inflammation | 0.60347476 |
| 99 | MP0002060_abnormal_skin_morphology | 0.59012275 |
| 100 | MP0009053_abnormal_anal_canal | 0.58951237 |
| 101 | MP0005397_hematopoietic_system_phenotyp | 0.58634975 |
| 102 | MP0001545_abnormal_hematopoietic_system | 0.58634975 |
| 103 | MP0009931_abnormal_skin_appearance | 0.58565476 |
| 104 | MP0000733_abnormal_muscle_development | 0.58460631 |
| 105 | MP0005501_abnormal_skin_physiology | 0.58213533 |
| 106 | MP0006035_abnormal_mitochondrial_morpho | 0.57759258 |
| 107 | MP0010155_abnormal_intestine_physiology | 0.57030191 |
| 108 | MP0002396_abnormal_hematopoietic_system | 0.56844716 |
| 109 | MP0001958_emphysema | 0.55390792 |
| 110 | MP0003303_peritoneal_inflammation | 0.55192658 |
| 111 | MP0000639_abnormal_adrenal_gland | 0.52488479 |
| 112 | MP0005395_other_phenotype | 0.52465517 |
| 113 | MP0005448_abnormal_energy_balance | 0.51598950 |
| 114 | MP0003638_abnormal_response/metabolism_ | 0.48977464 |
| 115 | MP0005464_abnormal_platelet_physiology | 0.48166530 |
| 116 | MP0003724_increased_susceptibility_to | 0.44741543 |
| 117 | MP0005058_abnormal_lysosome_morphology | 0.44161959 |
| 118 | MP0002822_catalepsy | 0.44127734 |
| 119 | MP0003953_abnormal_hormone_level | 0.43732420 |
| 120 | MP0005666_abnormal_adipose_tissue | 0.43445755 |
| 121 | MP0003718_maternal_effect | 0.43108126 |
| 122 | MP0008874_decreased_physiological_sensi | 0.42759304 |
| 123 | MP0002168_other_aberrant_phenotype | 0.40237429 |
| 124 | MP0009672_abnormal_birth_weight | 0.39149497 |
| 125 | MP0004782_abnormal_surfactant_physiolog | 0.38906707 |
| 126 | MP0003075_altered_response_to | 0.38767162 |
| 127 | MP0000230_abnormal_systemic_arterial | 0.38520608 |
| 128 | MP0004381_abnormal_hair_follicle | 0.36749687 |
| 129 | MP0005166_decreased_susceptibility_to | 0.36749489 |
| 130 | MP0003436_decreased_susceptibility_to | 0.36651106 |
| 131 | * MP0001765_abnormal_ion_homeostasis | 0.36590226 |
| 132 | MP0002837_dystrophic_cardiac_calcinosis | 0.35929885 |
| 133 | MP0008872_abnormal_physiological_respon | 0.35637024 |
| 134 | * MP0008873_increased_physiological_sensi | 0.34681590 |
| 135 | MP0002796_impaired_skin_barrier | 0.34294690 |
| 136 | MP0009384_cardiac_valve_regurgitation | 0.32098477 |
| 137 | MP0005248_abnormal_Harderian_gland | 0.32025061 |
| 138 | MP0009115_abnormal_fat_cell | 0.31564222 |
| 139 | MP0000579_abnormal_nail_morphology | 0.31084956 |
| 140 | MP0004147_increased_porphyrin_level | 0.29870859 |
| 141 | MP0002970_abnormal_white_adipose | 0.29647172 |
| 142 | MP0002135_abnormal_kidney_morphology | 0.29609155 |
| 143 | MP0004264_abnormal_extraembryonic_tissu | 0.28636675 |
| 144 | MP0006082_CNS_inflammation | 0.28635060 |
| 145 | MP0003300_gastrointestinal_ulcer | 0.27313622 |
| 146 | MP0000249_abnormal_blood_vessel | 0.27282025 |
| 147 | MP0001853_heart_inflammation | 0.26837943 |
| 148 | MP0001243_abnormal_dermal_layer | 0.26679357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.25415286 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.11782160 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.99490775 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.46828760 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.17678916 |
| 6 | Xanthomatosis (HP:0000991) | 6.08053936 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.98948812 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.18422045 |
| 9 | Complement deficiency (HP:0004431) | 5.12176509 |
| 10 | Hyperammonemia (HP:0001987) | 4.62784676 |
| 11 | Joint hemorrhage (HP:0005261) | 4.59649967 |
| 12 | Hyperglycinemia (HP:0002154) | 4.51847733 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.48387797 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.46520824 |
| 15 | Ketosis (HP:0001946) | 4.41694085 |
| 16 | Epidermoid cyst (HP:0200040) | 4.29431612 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.25253819 |
| 18 | Hyperglycinuria (HP:0003108) | 4.23060411 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.20900468 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 4.20186186 |
| 21 | Abnormality of glycine metabolism (HP:0010895) | 4.13511301 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.13511301 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.08841175 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 4.07070433 |
| 25 | Fat malabsorption (HP:0002630) | 4.02262684 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.91541115 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.85347649 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.74266612 |
| 29 | Abnormality of complement system (HP:0005339) | 3.70983740 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.66985276 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.57984718 |
| 32 | Broad face (HP:0000283) | 3.54857809 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.43317263 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.37746040 |
| 35 | Hyperbilirubinemia (HP:0002904) | 3.35672952 |
| 36 | Abnormality of nucleobase metabolism (HP:0010932) | 3.32554538 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.28391763 |
| 38 | Ketoacidosis (HP:0001993) | 3.26206068 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.24506958 |
| 40 | Gout (HP:0001997) | 3.20958151 |
| 41 | Abnormality of purine metabolism (HP:0004352) | 3.11698502 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.09646839 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 3.05738358 |
| 44 | Steatorrhea (HP:0002570) | 2.99232638 |
| 45 | Thin bony cortex (HP:0002753) | 2.87557096 |
| 46 | Metabolic acidosis (HP:0001942) | 2.87433839 |
| 47 | Hypochromic microcytic anemia (HP:0004840) | 2.83547936 |
| 48 | Cervical subluxation (HP:0003308) | 2.80777077 |
| 49 | Myocardial infarction (HP:0001658) | 2.79693385 |
| 50 | Vascular calcification (HP:0004934) | 2.75767250 |
| 51 | Spontaneous abortion (HP:0005268) | 2.75389020 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.72170895 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.72170895 |
| 54 | Cerebral aneurysm (HP:0004944) | 2.71687711 |
| 55 | Lethargy (HP:0001254) | 2.70540151 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.68141286 |
| 57 | J-shaped sella turcica (HP:0002680) | 2.66733541 |
| 58 | Abnormality of the Achilles tendon (HP:0005109) | 2.65286276 |
| 59 | Ulnar bowing (HP:0003031) | 2.63259699 |
| 60 | Mucopolysacchariduria (HP:0008155) | 2.62569993 |
| 61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.62569993 |
| 62 | Skin nodule (HP:0200036) | 2.62245160 |
| 63 | Flat acetabular roof (HP:0003180) | 2.61460360 |
| 64 | Obstructive sleep apnea (HP:0002870) | 2.61022085 |
| 65 | Biconcave vertebral bodies (HP:0004586) | 2.57408991 |
| 66 | Acanthocytosis (HP:0001927) | 2.57083289 |
| 67 | Generalized aminoaciduria (HP:0002909) | 2.48630952 |
| 68 | Spastic diplegia (HP:0001264) | 2.46830848 |
| 69 | Hypoglycemic seizures (HP:0002173) | 2.46534053 |
| 70 | Irritability (HP:0000737) | 2.43970863 |
| 71 | Cardiovascular calcification (HP:0011915) | 2.43913568 |
| 72 | Cerebral edema (HP:0002181) | 2.42993710 |
| 73 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.41468679 |
| 74 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.41468679 |
| 75 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.41468679 |
| 76 | Abnormal gallbladder morphology (HP:0012437) | 2.41442268 |
| 77 | Neonatal onset (HP:0003623) | 2.40222924 |
| 78 | Reticulocytosis (HP:0001923) | 2.36284427 |
| 79 | Cholelithiasis (HP:0001081) | 2.35772441 |
| 80 | Malnutrition (HP:0004395) | 2.35695666 |
| 81 | Protrusio acetabuli (HP:0003179) | 2.35678755 |
| 82 | Mitral stenosis (HP:0001718) | 2.32378808 |
| 83 | Abnormal gallbladder physiology (HP:0012438) | 2.30591208 |
| 84 | Cholecystitis (HP:0001082) | 2.30591208 |
| 85 | Glomerulonephritis (HP:0000099) | 2.29774431 |
| 86 | Enlarged kidneys (HP:0000105) | 2.29761760 |
| 87 | Nephritis (HP:0000123) | 2.27122866 |
| 88 | Sensorimotor neuropathy (HP:0007141) | 2.26863872 |
| 89 | Asymmetry of the thorax (HP:0001555) | 2.26471290 |
| 90 | Alkalosis (HP:0001948) | 2.25647081 |
| 91 | Late onset (HP:0003584) | 2.24289577 |
| 92 | Proximal tubulopathy (HP:0000114) | 2.24127730 |
| 93 | Vomiting (HP:0002013) | 2.22763839 |
| 94 | Hyperacusis (HP:0010780) | 2.22629037 |
| 95 | Dysostosis multiplex (HP:0000943) | 2.22281622 |
| 96 | Stridor (HP:0010307) | 2.21174810 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.20899740 |
| 98 | Rickets (HP:0002748) | 2.19095676 |
| 99 | Increased purine levels (HP:0004368) | 2.17804434 |
| 100 | Hyperuricemia (HP:0002149) | 2.17804434 |
| 101 | Abnormality of the thoracic spine (HP:0100711) | 2.16720141 |
| 102 | Esophageal varix (HP:0002040) | 2.15835500 |
| 103 | Pancreatitis (HP:0001733) | 2.15374547 |
| 104 | Lymphangioma (HP:0100764) | 2.14211811 |
| 105 | Purpura (HP:0000979) | 2.14007859 |
| 106 | Hydroxyprolinuria (HP:0003080) | 2.10216003 |
| 107 | Abnormality of proline metabolism (HP:0010907) | 2.10216003 |
| 108 | Amyloidosis (HP:0011034) | 2.09485181 |
| 109 | Brushfield spots (HP:0001088) | 2.08098135 |
| 110 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.05485081 |
| 111 | Menorrhagia (HP:0000132) | 2.05397410 |
| 112 | Bronchomalacia (HP:0002780) | 2.03948856 |
| 113 | Opisthotonus (HP:0002179) | 2.03734843 |
| 114 | Abnormality of urine glucose concentration (HP:0011016) | 2.03169068 |
| 115 | Glycosuria (HP:0003076) | 2.03169068 |
| 116 | Achilles tendon contracture (HP:0001771) | 2.03081429 |
| 117 | Gingival bleeding (HP:0000225) | 2.03068537 |
| 118 | Thrombophlebitis (HP:0004418) | 2.02465657 |
| 119 | Poikilocytosis (HP:0004447) | 2.02335951 |
| 120 | Abnormality of the gallbladder (HP:0005264) | 2.00417548 |
| 121 | Hypertriglyceridemia (HP:0002155) | 1.99909556 |
| 122 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99891836 |
| 123 | Hypophosphatemic rickets (HP:0004912) | 1.94057088 |
| 124 | Aneurysm (HP:0002617) | 1.93637306 |
| 125 | Hemorrhage of the eye (HP:0011885) | 1.91156170 |
| 126 | Colitis (HP:0002583) | 1.87809969 |
| 127 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86686212 |
| 128 | Abnormality of carpal bone ossification (HP:0006257) | 1.86603623 |
| 129 | Abnormal cartilage morphology (HP:0002763) | 1.85594643 |
| 130 | Abnormality of iron homeostasis (HP:0011031) | 1.84066713 |
| 131 | Abnormality of the fingertips (HP:0001211) | 1.83608958 |
| 132 | Neonatal hypoglycemia (HP:0001998) | 1.83237548 |
| 133 | Disproportionate tall stature (HP:0001519) | 1.82267252 |
| 134 | Renal cortical cysts (HP:0000803) | 1.81882380 |
| 135 | Elevated alkaline phosphatase (HP:0003155) | 1.81084696 |
| 136 | Vertebral compression fractures (HP:0002953) | 1.80635105 |
| 137 | Impaired platelet aggregation (HP:0003540) | 1.80330520 |
| 138 | Abnormal platelet function (HP:0011869) | 1.80330520 |
| 139 | Thoracic kyphosis (HP:0002942) | 1.79111418 |
| 140 | Increased serum ferritin (HP:0003281) | 1.77869131 |
| 141 | Blue sclerae (HP:0000592) | 1.77186942 |
| 142 | Self-mutilation (HP:0000742) | 1.76513195 |
| 143 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.74221994 |
| 144 | Upper limb amyotrophy (HP:0009129) | 1.73144520 |
| 145 | Distal upper limb amyotrophy (HP:0007149) | 1.73144520 |
| 146 | Abnormal ossification of hand bones (HP:0005921) | 1.72694429 |
| 147 | Advanced eruption of teeth (HP:0006288) | 1.71101941 |
| 148 | Sparse lateral eyebrow (HP:0005338) | 1.70300881 |
| 149 | Distal lower limb amyotrophy (HP:0008944) | 1.69604198 |
| 150 | Short nail (HP:0001799) | 1.64708526 |
| 151 | Increased connective tissue (HP:0009025) | 1.63942339 |
| 152 | Deformed sella turcica (HP:0002681) | 1.62394432 |
| 153 | Hypophosphatemia (HP:0002148) | 1.62232880 |
| 154 | Epistaxis (HP:0000421) | 1.59144595 |
| 155 | Premature skin wrinkling (HP:0100678) | 1.58423102 |
| 156 | Seborrheic dermatitis (HP:0001051) | 1.57160539 |
| 157 | Bifid scrotum (HP:0000048) | 1.56987876 |
| 158 | Visceral angiomatosis (HP:0100761) | 1.54072990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.20473935 |
| 2 | FGFR4 | 4.48340040 |
| 3 | SIK1 | 4.32026073 |
| 4 | ERN1 | 4.25166621 |
| 5 | INSRR | 3.08161858 |
| 6 | TAOK3 | 3.07654733 |
| 7 | ERBB4 | 2.86670719 |
| 8 | EEF2K | 2.76191921 |
| 9 | SMG1 | 2.66579822 |
| 10 | MST1R | 2.30896571 |
| 11 | CDK12 | 2.28953296 |
| 12 | MAP2K4 | 2.19258604 |
| 13 | EPHA2 | 2.11822030 |
| 14 | PRPF4B | 2.07384843 |
| 15 | MAPK11 | 1.95540742 |
| 16 | PKN2 | 1.94879529 |
| 17 | FLT3 | 1.76500806 |
| 18 | PIK3CG | 1.75403418 |
| 19 | TRIB3 | 1.66674877 |
| 20 | TYK2 | 1.61741880 |
| 21 | LATS1 | 1.60269791 |
| 22 | TNK2 | 1.52885520 |
| 23 | PTK6 | 1.49936516 |
| 24 | PRKD3 | 1.47579571 |
| 25 | ABL2 | 1.46182104 |
| 26 | DAPK2 | 1.40612572 |
| 27 | PDGFRA | 1.40311351 |
| 28 | MARK2 | 1.38661706 |
| 29 | FRK | 1.35698738 |
| 30 | NEK9 | 1.33549682 |
| 31 | STK38L | 1.33162228 |
| 32 | AKT3 | 1.31598304 |
| 33 | MAP4K1 | 1.31460445 |
| 34 | PRKD2 | 1.30725908 |
| 35 | MAP3K7 | 1.28964235 |
| 36 | WNK4 | 1.27974608 |
| 37 | TTN | 1.22706220 |
| 38 | JAK2 | 1.22027886 |
| 39 | KDR | 1.21467601 |
| 40 | FGFR2 | 1.19325591 |
| 41 | PRKAA2 | 1.16885997 |
| 42 | PINK1 | 1.16260652 |
| 43 | GRK6 | 1.15819909 |
| 44 | TAOK1 | 1.14697907 |
| 45 | WNK3 | 1.07714762 |
| 46 | MAP2K3 | 1.05420743 |
| 47 | MAP3K14 | 1.02478777 |
| 48 | EPHB1 | 1.01829113 |
| 49 | ERBB2 | 1.01083993 |
| 50 | MAPK15 | 0.99876535 |
| 51 | TBK1 | 0.98801994 |
| 52 | ZAP70 | 0.98266765 |
| 53 | CDC42BPA | 0.97720356 |
| 54 | JAK1 | 0.97019762 |
| 55 | MAP3K10 | 0.92371288 |
| 56 | PRKCZ | 0.92047452 |
| 57 | MAPK4 | 0.91889028 |
| 58 | MAP3K3 | 0.91285275 |
| 59 | MET | 0.89198104 |
| 60 | SIK2 | 0.85301544 |
| 61 | RPS6KA2 | 0.85029162 |
| 62 | DYRK1B | 0.81740390 |
| 63 | GSK3A | 0.81162788 |
| 64 | SGK3 | 0.79866644 |
| 65 | IRAK3 | 0.78365908 |
| 66 | MAPK12 | 0.77740925 |
| 67 | MAP3K11 | 0.77339821 |
| 68 | OXSR1 | 0.75620920 |
| 69 | PRKACG | 0.75215716 |
| 70 | TIE1 | 0.75132952 |
| 71 | PRKAA1 | 0.73890540 |
| 72 | CAMKK1 | 0.71710691 |
| 73 | LMTK2 | 0.71344503 |
| 74 | CDK6 | 0.70717839 |
| 75 | CAMK1D | 0.69071243 |
| 76 | PAK4 | 0.67749882 |
| 77 | CSK | 0.67182843 |
| 78 | HIPK2 | 0.66393206 |
| 79 | RPS6KL1 | 0.66060062 |
| 80 | RPS6KC1 | 0.66060062 |
| 81 | BLK | 0.65557827 |
| 82 | SGK494 | 0.65238663 |
| 83 | SGK223 | 0.65238663 |
| 84 | CDK7 | 0.64704932 |
| 85 | EPHA3 | 0.64693129 |
| 86 | CAMK2G | 0.64224394 |
| 87 | TGFBR2 | 0.63455902 |
| 88 | PTK2 | 0.61148271 |
| 89 | RIPK1 | 0.60351994 |
| 90 | SGK2 | 0.59775913 |
| 91 | PDPK1 | 0.58655094 |
| 92 | TYRO3 | 0.56745382 |
| 93 | MAP2K6 | 0.55198281 |
| 94 | RIPK4 | 0.53880523 |
| 95 | MAPKAPK3 | 0.53748861 |
| 96 | IKBKE | 0.52632573 |
| 97 | BMX | 0.51738350 |
| 98 | CHUK | 0.51231628 |
| 99 | KSR2 | 0.50713683 |
| 100 | MAPK7 | 0.49996870 |
| 101 | CSNK1G1 | 0.48871896 |
| 102 | PRKCQ | 0.48646087 |
| 103 | CSF1R | 0.48393377 |
| 104 | DDR2 | 0.47953549 |
| 105 | IRAK4 | 0.47024282 |
| 106 | RPS6KA6 | 0.46964801 |
| 107 | FGFR3 | 0.46901107 |
| 108 | PDGFRB | 0.45378094 |
| 109 | PDK3 | 0.41951876 |
| 110 | PDK4 | 0.41951876 |
| 111 | MAP3K5 | 0.40572481 |
| 112 | ICK | 0.40434114 |
| 113 | PKN1 | 0.39631303 |
| 114 | TAOK2 | 0.39291471 |
| 115 | GRK1 | 0.39236413 |
| 116 | IGF1R | 0.39161504 |
| 117 | MTOR | 0.38343602 |
| 118 | CDK4 | 0.36873948 |
| 119 | MAP3K13 | 0.36638716 |
| 120 | PRKCG | 0.35809477 |
| 121 | MAP3K2 | 0.35529610 |
| 122 | RPS6KB2 | 0.35396797 |
| 123 | MAP2K1 | 0.35161174 |
| 124 | BTK | 0.34807678 |
| 125 | JAK3 | 0.34767965 |
| 126 | PDK1 | 0.34636298 |
| 127 | MAPK8 | 0.33351272 |
| 128 | NTRK1 | 0.31906583 |
| 129 | EGFR | 0.31642370 |
| 130 | CAMK1G | 0.31446218 |
| 131 | RET | 0.31411701 |
| 132 | WNK1 | 0.31321352 |
| 133 | PIM2 | 0.31085133 |
| 134 | CAMK4 | 0.30902865 |
| 135 | BRD4 | 0.30782578 |
| 136 | MAP3K6 | 0.30736036 |
| 137 | RPS6KA1 | 0.30516380 |
| 138 | EPHA4 | 0.30417214 |
| 139 | PAK2 | 0.29845956 |
| 140 | MAPK3 | 0.29137499 |
| 141 | MELK | 0.28766375 |
| 142 | IRAK1 | 0.27132114 |
| 143 | MAP3K1 | 0.26792423 |
| 144 | PRKCA | 0.26654345 |
| 145 | MAP2K2 | 0.26374144 |
| 146 | STK38 | 0.26021269 |
| 147 | NEK1 | 0.25845445 |
| 148 | PBK | 0.24785409 |
| 149 | IRAK2 | 0.23995477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.38411673 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.51774110 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.46604887 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.31903672 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 3.02222412 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.96707298 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.70872740 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69345290 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.61088548 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.60148356 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.55078770 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.49248985 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.44723286 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.39956012 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.30337034 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.14149853 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09612730 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.00721091 |
| 19 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89378504 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88907983 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.87466718 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86350709 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82939254 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80948743 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74648619 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.74609402 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73139213 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.71164713 |
| 29 | Retinol metabolism_Homo sapiens_hsa00830 | 1.64628018 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.63482171 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.62104715 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59930473 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.59836083 |
| 34 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58204581 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.54141793 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52510875 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.47003717 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45969211 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.40106274 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36874987 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.32470945 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29786189 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27719881 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23677817 |
| 45 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.20574794 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.19542496 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18624245 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18527749 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16640228 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14118348 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.09904525 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09627480 |
| 53 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07666674 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07566953 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.07290518 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04735691 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04279621 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00797403 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96481587 |
| 60 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95922638 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94165972 |
| 62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92355160 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89061832 |
| 64 | Lysine degradation_Homo sapiens_hsa00310 | 0.86770795 |
| 65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.83565791 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83237609 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79115248 |
| 68 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74335297 |
| 69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73896795 |
| 70 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73430866 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69608590 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.64955712 |
| 73 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.63950101 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.61579959 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59133302 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58688184 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55453267 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54501039 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53336930 |
| 80 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52959122 |
| 81 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.51676714 |
| 82 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48965505 |
| 83 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47836504 |
| 84 | Pertussis_Homo sapiens_hsa05133 | 0.47120739 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46527362 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.45853764 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.45584817 |
| 88 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42435491 |
| 89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41613099 |
| 90 | Prostate cancer_Homo sapiens_hsa05215 | 0.39745080 |
| 91 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38662427 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.38486424 |
| 93 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38399519 |
| 94 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38312309 |
| 95 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.37217129 |
| 96 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36647829 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.35861908 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34074942 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34046880 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33180101 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.30821708 |
| 102 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26908506 |
| 103 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24869468 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23873384 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.23553100 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22386447 |
| 107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21023561 |
| 108 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17402551 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13218897 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08931494 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02339170 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2270384 |
| 113 | Lysosome_Homo sapiens_hsa04142 | -0.2254909 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.2171941 |
| 115 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2010419 |
| 116 | Mineral absorption_Homo sapiens_hsa04978 | -0.1954197 |
| 117 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1857056 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1820491 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1745761 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | -0.1629250 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1522956 |
| 122 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1493155 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1475152 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1435944 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1289550 |
| 126 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1268872 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1098481 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1051939 |
| 129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0912228 |
| 130 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0895154 |
| 131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0775807 |
| 132 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0166418 |

